Chemotherapy for disseminated testicular cancer.

L. H. Einhorn, J. P. Donohue

Research output: Contribution to journalArticle

33 Scopus citations

Abstract

Fifty patients with disseminated testicular cancer were treated with a three-drug combination consisting of cis-diaminedichloroplatinum, vinblastine, and bleomycin. Three patients were considered unevaluable due to early death. This chemotherapy regimen produced 74 per cent complete and 26 per cent partial remissions. Furthermore, five patients in partial remission became disease-free following the surgical removal of residual disease, producing an overall 85 per cent disease-free status. Toxicity, although significant during remission induction with cis-platinum, vinblastine, and bleomycin, was usually manageable. Maintenance therapy with vinblastine and BCG was very well tolerated, and only two patients in complete remission have experienced a relapse on maintenance therapy, one of whom had a central nervous system relapse. Thirty eight of these patients remain alive, and 32 remain alive and disease-free 6+ to 30+ months. We feel that this regimen represents a major advance in the management of patients with disseminated testicular cancer.

Original languageEnglish (US)
Pages (from-to)407-426
Number of pages20
JournalUrologic Clinics of North America
Volume4
Issue number3
StatePublished - Oct 1 1977
Externally publishedYes

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Chemotherapy for disseminated testicular cancer.'. Together they form a unique fingerprint.

  • Cite this